Showing results (1521-1530 of 3,791) with videos related to

Sort By:
Pageof 380
Oncoimmunology|October 26, 2020
Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosisVarun Sasidharan Nair, Reem Saleh, Rowaida Z Taha, et al.
Oncoimmunology|October 28, 2020
Small-molecule PD-L1 inhibitor BMS1166 abrogates the function of PD-L1 by blocking its ER exportFang-Fang Chen, Zheng Li, Dawei Ma, et al.
Oncoimmunology|November 25, 2020
Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]Satoshi Takeuchi, Masahiro Kagabu, Tadahiro Shoji, et al.
Oncoimmunology|November 5, 2020
Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinomaQunfang Zhang, Haiding Huang, Fang Zheng, et al.
Oncoimmunology|November 5, 2020
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockadeKarsten A Pilones, Michal Hensler, Camille Daviaud, et al.
Oncoimmunology|November 12, 2020
Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockersSoleine Medjebar, Caroline Truntzer, Anaïs Perrichet, et al.
Oncoimmunology|October 29, 2021
PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancerMohanad H Nada, Hong Wang, Auter J Hussein, et al.
Oncoimmunology|July 11, 2022
PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cellsCecilia Pesini, Sandra Hidalgo, Maykel A Arias, et al.
Oncoimmunology|July 11, 2022
Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressivenessElena Poli, Vanessa Barbon, Silvia Lucchetta, et al.
Oncoimmunology|July 18, 2022
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regressionTatiana V Kudling, James H A Clubb, Dafne C A Quixabeira, et al.
Pageof 380